Medtronic (MDT)
89.90
-2.91 (-3.14%)
NYSE · Last Trade: Aug 19th, 11:59 PM EDT
Medtronic's Q1 wasn't horrible. It also wasn't good enough to justify the stock price.
Via The Motley Fool · August 19, 2025
Tech stocks pulled back on Tuesday as the absence of fresh bullish catalysts prompted investors to take profits after the recent months-long rally.
Via Benzinga · August 19, 2025
Via Benzinga · August 19, 2025
Via Benzinga · August 19, 2025
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
Via Chartmill · August 19, 2025
Medtronic is on track to complete a market reversal in 2025. Sell-siders, including activists, analysts, and institutions, are buying this stock in 2025.
Via MarketBeat · August 19, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · August 19, 2025
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · August 19, 2025
Medtronic stock slipped Tuesday as an activist investor's actions overshadowed a strong fiscal first-quarter report.
Via Investor's Business Daily · August 19, 2025
Medtronic posts stronger Q1 results, raises fiscal 2026 outlook, adds new board members, and sets 2026 Investor Day amid portfolio shifts.
Via Benzinga · August 19, 2025
Elliott Partner Marc Steinberg stated that the decision to become one of the largest investors in Medtronic was driven by the conviction that the company is entering a new chapter of value creation.
Via Stocktwits · August 19, 2025
While Dow Jones futures edged lower by 0.04% at the time of writing, the S&P 500 futures fell 0.12%.
Via Stocktwits · August 19, 2025
Medtronic (MDT) beats Q1 FY26 earnings and revenue estimates, marking 11 straight quarters of mid-single-digit organic growth. The stock dipped slightly in pre-market trading.
Via Chartmill · August 19, 2025
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.
Via Benzinga · August 18, 2025
Via Benzinga · August 18, 2025
Retail investor favorites reporting earnings this week.
Via Benzinga · August 18, 2025
Discover Medtronic PLC (MDT) as a high-probability breakout stock with strong technicals, consolidation, and low-risk entry points for momentum traders.
Via Chartmill · August 15, 2025
Its stock has been languishing for a while, but management is working to get back on the growth track.
Via The Motley Fool · August 14, 2025
If you have decades to go before you retire, you want to make sure you own companies that know how to survive and thrive.
Via The Motley Fool · August 13, 2025
These top dividend stocks are steadily marching toward the throne room.
Via The Motley Fool · August 12, 2025
A longtime leader in financial services tops the list.
Via The Motley Fool · August 11, 2025